VICC earns accreditation for human research subjects protection
The News Review:
- VICC earns accreditation for human research subjects protection
- Growing Midwestern Clinical Research rganization Selects mniComm …
- Clinical trials set for vaccine for H1N1 virus
- Invitrogen Launches Biomarker Tool for Pre-Clinical Research into …
VICC earns accreditation for human research subjects protection
Vanderbilt University News
The goal is to ensure that all participants are respected and protected from unnecessary harm.
To earn accreditation organizations must provide tangible evidence of their adherence to scientifically and ethically sound research.
Accreditation is the gold standard for research organizations to demonstrate this ethical behavior and to build confidence among patients in the quality of clinical research. js’>©2009 Vanderbilt Medical CenterEditorial tool created by Vanderbilt Medical Center Web DevelopmentSEARCH THE REPRTER.
Growing Midwestern Clinical Research rganization Selects mniComm …
PR Newswire (press release) (press release)
(TCBulletinBoard: MCM) a leader in integrated electronic data capture (EDC) solutions for clinical trials announced today that a growing US Clinical Research rganization (CR) has selected mniComm to provide eClinical solutions in connection with two of the CR’s Phase IV studies covering approximately 27 sites and more than 700 subjects. Additional details were not disclosed. “We are pleased to have been selected by this CR to provide eClinical solutions for these important Phase IV studies” said Cornelis F. Wit mniComm’s President and CE.
Clinical trials set for vaccine for H1N1 virus
Middletown Journal
Prestige Clinical Research at 333 Conover Drive Suite D is set to begin human trials mid-month said Dr. Gary Bedel principal investigator for Prestige. He said the center would be enrolling candidates for the trial through mid-September. Bedel said there are two primary groups that will be targeted at the Franklin center: children ages 3 to 9 and adults 65 and older. “We are trying to get as many people involved as possible” Bedel said.
Related from Cghyjx: Hualan Biological starts A/H1N1 vaccine R & D
Invitrogen Launches Biomarker Tool for Pre-Clinical Research into …
Business Wire (press release)
Shames Assistant Professor of Surgery Division of Transplant Surgery at the Medical College of Wisconsin “Development of a non-invasive test that could help differentiate between acute renal injury rejection and infection would satisfy a critical unmet need in transplantation. A biomarker test that can accomplish this would be of extreme importance in pre-clinical kidney transplantation research. ” Jim Janicki Vice President and General Manager of Life Technologies’ Transplantation Diagnostics Business “The launch of the PlexMark assay represents the continued expansion of our pre-clinical research business. We are excited about the non-invasive and cost-effective nature of PlexMark and anticipate that research clinicians will want to utilize this product to better understand immunosuppression as it relates to whole kidney function. ” Resources.
Written by admin on August 1st, 2009 with
no comments.
Read more articles on News.